It’s always good news when the scientists discover new preventative drug free migraine therapies to help chronic migraine sufferers break their reliance on powerful and expensive headache medication. According to news.com.au, researchers are in the final stages of clinical trials that will hopefully result in the development of a migraine vitamin.
This particular treatment is designed for migraineurs with a specific, MTHR methylene tetrahydrofolate reductase, gene mutation. This condition leads to a lower production level of a certain enzyme that controls folate and the non-protein amino acid homocysteine. The vitamin under development could support enzyme production that would lower homocysteine levels, associated with migraines.
The chief researcher on this project was an author of a 2009 study from the Griffith University in Gold Coast, Australia. In that study, vitamin therapy was shown to be a promising preventative drug free migraine treatment as it diminished headache symptoms and occurrence frequency among the subjects who also had this specific gene mutation.
This study was published in Pharmacogenet Genomics. Recent medical research has proven in many cases, that there is a genetic connection when it comes to chronic migraines. According to the Australian news site, the researcher said “I suffered from migraine as a teenager, my mum suffered from migraine, but as a geneticist looking at genes for various disorders I didn’t even think about migraine until my son at about the age of four started suffering from migraine, including visual disturbances.”
From trigger avoidance, to supplementation, interventional pain management and migraine surgical procedures—it is certainly exciting how many drug free migraine treatment options are currently available to individuals struggling with debilitating symptoms of pain and nausea.
These treatments are becoming increasingly valuable as we learn more and more about the unpleasant side effects that accompany many medications. When so many people are being treated with drugs for a myriad of ailments, the likelihood of adding migraine medication certainly increases the chance for adverse interactions among the substances. We will look forward to future development in this effort from the Land Down Under.